Safety and Efficacy of Recombinant Birch Pollen Allergen in the Treatment of Allergic Rhinoconjunctivitis
PHASE3CompletedINTERVENTIONAL
Timeline
Start Date
December 31, 2003
Primary Completion Date
June 30, 2006
Study Completion Date
June 30, 2009
Conditions
Birch Pollen Allergy
Interventions
BIOLOGICAL
Recombinant birch pollen
Trial Locations (1)
21465
Allergopharma GmbH & Co. KG, Reinbek
All Listed Sponsors
lead
Allergopharma GmbH & Co. KG
INDUSTRY
NCT00309062 - Safety and Efficacy of Recombinant Birch Pollen Allergen in the Treatment of Allergic Rhinoconjunctivitis | Biotech Hunter | Biotech Hunter